Company Info






  Home > Archived Webinars >

Emerging Diagnostic Technologies: Proving the Clinical Application through Gold Standard Data



 
Our Price: $395.00

Product Code: WB-7068
Qty:

Product Info
 
About the Product
Includes 1 hour and 5 minute Windows Media Video File and PowerPoint presentations for immediate download.


With the ability to produce vast amounts of data at an extremely low price, next generation sequencing (NGS) technologies are predicted to become one of the most valuable clinical tools in personalized medicine, and diagnostic manufacturers are exploring a variety of NGS strategies and approaches as uncertainty remains around critical areas such as the extent to which clinicians will adopt these novel technologies, as well as identifying ways to effectively demonstrate their clinical value in the current regulatory and reimbursement environment. The following presentation will provide clinical research professionals with a primer on key considerations in the clinical application of genomic sequencing.
  • Pre-development considerations and requirements
  • Risk-based review of available technical platforms
  • Clarification of the clinical questions: the right sample, gold standard, and reimbursement strategy

Speaker:

Lyssa Friedman
Clinical Operations Executive
In-Vitro Diagnostic and Biotechnology Industries


Participants that will find this webinar most beneficial will be those involved in diagnostic companies. Job titles of attendees that will be most applicable for this session will be:

  • Clinical Operations
  • Regulatory

Share your knowledge of this product. Be the first to write a review »